Table 1.
Sample and population prevalence of the main biological and behavioral indicators
n/N | Sample prevalence (%) | Estimated population prevalence (%) | Population prevalence 95% CI | Equilibrium reached at wave # | |
---|---|---|---|---|---|
HBV | 5/192 | 2.5 | 0.6 | 0.1–1.4 | 2 |
HCV | 84/192 | 45.2 | 40.3 | 29.2–52.2 | 2 |
Did not share injecting equipment in the last week | 77/192 | 41.2 | 72.9 | 61.3–79.5 | 5 |
Used sterile injecting equipment when last injected | 132/192 | 68.8 | 90.4 | 85.2–94.2 | 1 |
More than one sexual partner in the past year | 73/192 | 38.0 | 29.2 | 20.8–40.2 | 2 |
Used a condom at most recent sexual intercourse | 50/187 | 26.4 | 34.2 | 20.4–45.5 | 2 |
Consistent use of condoms in the past month | 21/94 | 20.8 | 30.2 | 13.0–54.2 | 2 |
Sold or bought/exchanged sex in the last 12 months | 56/192 | 27.5 | 24.8 | 14.6–33.2 | 2 |
Experience of anal intercourse (ever) | 51/187 | 26.4 | 24.6 | 14.9–34.0 | 2 |
Correctly identifies ways of preventing HIV transmission and rejects major misconceptions about HIV transmissiona | 37/192 | 19.3 | 17.4 | 10.2–25.3 | 2 |
Ever tested for HIV | 112/189 | 61.1 | 66.3 | 55.6–76.5 | 4 |
Seeds (n = 7) were excluded from analyses
aAnswered correctly all five UNGASS HIV knowledge indicators